Researchers at Baylor College of Medicine will study the link between exposure to battlefield chemicals and prostate cancer (PC) in U.S. veterans with a $1 million Challenge Award from the Prostate Cancer Foundation.
The goal is to better understand specific mutations or changes in expression that might have occurred as a result of exposure to toxic materials on the battlefield.
Researchers will study patients at the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC) and Harris Health’s Ben Taub Hospital, two Houston-based healthcare facilities serving a large number of veterans with PC.
Jeffrey Jones, MD, chief of urology at MEDVAMC and the study’s lead investigator, will lead a team that selects patients for the project, collects blood and tissue samples from veterans with PC, and conducts translational and clinical studies. The team hopes to develop new biotechnologies for diagnosing and treating PC patients. It also will investigate the genomics, metabolomics, and epigenomics of unique tumor specimens from these patients.